| Line Item | Jun 30, 2026 | Mar 31, 2026 | Jun 30, 2025 | Mar 31, 2025 |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Gross margin | ||||
| % of revenue | 84.8% | -96.4% | ||
| Operating expenses: | ||||
| Selling, general and administrative | ||||
| Research and development | ||||
| Total operating expenses | ||||
| % of revenue | 3448.6% | 22095.7% | ||
| Loss from operations | ||||
| % of revenue | -3363.7% | -22192.2% | ||
| Other income (expense): | ||||
| Change in fair value of Simple Agreement for Future Equity ("SAFE") liability | — | |||
| Change in fair value of Equity Line of Credit ("ELOC") derivative | — | |||
| Other income | ||||
| Loss before income taxes | ||||
| Income tax expense | ||||
| Net loss | ||||
| % of revenue | -3384.7% | -21937.7% | ||
| Net loss per share of common stock, basic | ||||
| Net loss per share of common stock, diluted |